Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.00
+0.20 (0.46%)
Jul 9, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Biomedical
698.34M
Log In
Log In
Biomedical Growth
8.34%
Log In
Log In
Adjustments and Reversals
-17.69M
Log In
Log In
Adjustments and Reversals Growth
-58.73%
Log In
Log In
Consumer
-
Log In
Log In
Consumer Growth
-
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Taiwan
298.86M
Log In
Log In
Taiwan Growth
8.43%
Log In
Log In
United States
196.57M
Log In
Log In
United States Growth
-1.13%
Log In
Log In
Asia
75.12M
Log In
Log In
Asia Growth
-21.60%
Log In
Log In
Europe
58.98M
Log In
Log In
Europe Growth
111.19%
Log In
Log In
Other
51.13M
Log In
Log In
Other Growth
113.59%
Log In
Log In